Suppression of Wnt Signaling and Osteogenic Changes in Vascular Smooth Muscle Cells by Eicosapentaenoic Acid

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Vascular Biology

Background:

• Vascular medial calcification is linked to arteriosclerosis and cardiovascular events.
• Eicosapentaenoic acid (EPA) has demonstrated potential in suppressing vascular calcification.
• Wnt signaling is a key pathway implicated in vascular calcification.

Purpose of the Study:

• To investigate the inhibitory effects of Eicosapentaenoic acid (EPA) on Wnt signaling.
• To explore the role of EPA in vascular calcification through Wnt signaling modulation.

Main Methods:

• Assessed mRNA expression of Klotho, a Wnt signaling inhibitor, in wild-type mice.
• Analyzed beta-catenin levels in aortas of Klotho mutant mice.
• Utilized human aorta smooth muscle cells to examine EPA's effect on Wnt signaling markers (AXIN2, LEF1) and osteogenic genes (RUNX2, BMP4).
• Investigated the role of PPARγ activation using a PPARγ inhibitor (T0070907).

Main Results:

• EPA intake upregulated Klotho mRNA expression in mouse kidneys.
• Increased beta-catenin levels were observed in the aortas of Klotho mutant mice.
• EPA suppressed Wnt signaling and osteogenic gene upregulation in smooth muscle cells.
• The inhibitory effect of EPA was reversed by a PPARγ inhibitor.

Conclusions:

• Eicosapentaenoic acid (EPA) suppresses vascular calcification by inhibiting Wnt signaling in osteogenic vascular smooth muscle cells.
• PPARγ activation is involved in the mechanism by which EPA exerts its inhibitory effects.
• EPA represents a potential therapeutic strategy for managing vascular calcification.